Highbridge Capital Management LLC Vanda Pharmaceuticals Inc. Transaction History

Highbridge Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $733,030 - $1.05 Million	-52,173 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $77,973 - $109,830	6,068 Added 13.16%	52,173 $793,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $710,017 - $869,079	46,105	46,105 $826,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.